Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Laura Lorenzetti
Stay informed with Laura Lorenzetti’s coverage and analysis.
Page 42 of 73
Finance
Forget the Roundup cancer report, Monsanto’s worried about a stronger U.S. dollar
By
Laura Lorenzetti
Features
GoDaddy goes public and RadioShack lives on — 5 things to know today
By
Laura Lorenzetti
Features
Yoox buys Net-a-Porter, and IBM’s Internet of Things bet — 5 things to know today
By
Laura Lorenzetti
Retail
GNC amps up its supplement quality controls
By
Laura Lorenzetti
Features
Greece tries again and Ford brings back the Lincoln Continental — 5 things to know today
By
Laura Lorenzetti
Features
Ken Burns talks to Fortune about his latest project: a history of cancer
By
Laura Lorenzetti
Features
Five years in, Obamacare fears haven’t come to pass, study finds
By
Laura Lorenzetti
Features
Kraft, Heinz merge, and Facebook hosts a conference — 5 things to know today
By
Laura Lorenzetti
Features
Merck halts study in light of melanoma drug’s success
By
Laura Lorenzetti
Features
‘Open Humans’ platform wants to democratize your DNA for better medical research
By
Laura Lorenzetti
Features
Facebook courts the media and George Soros on Greece — 5 things to know today
By
Laura Lorenzetti
Features
Starbucks reins in race plan, RadioShack on the block, and Greece and Germany meet again — 5 things to know today
By
Laura Lorenzetti
International
Protesters, police clash as the European Central Bank opens its new headquarters
By
Laura Lorenzetti
Tech
Exclusive: Collective Health raises $38 million to scale its insurance platform
By
Laura Lorenzetti
Features
Mac & Cheese recall, Alibaba on sale and the Fed’s next step — 5 things to know today
By
Laura Lorenzetti